Pulmonx Corp Company Top Insiders

LUNG Stock  USD 6.79  0.37  5.76%   
Roughly 94 percent of Pulmonx Corp's insiders are activelly selling. The analysis of insiders' sentiment of trading Pulmonx Corp stock suggests that a large number of insiders are panicking at this time. Pulmonx Corp employs about 279 people. The company is managed by 14 executives with a total tenure of roughly 651 years, averaging almost 46.0 years of service per executive, having 19.93 employees per reported executive.

Pulmonx Corp's Insider Buying Vs Selling

6

 
Selling
 
Buying

Latest Trades

2024-10-17Glendon E French IIIDisposed 20000 @ 6.52View
2024-09-12Glendon E French IIIDisposed 20000 @ 8.09View
2024-09-03Geoffrey Beran RoseDisposed 4586 @ 6.7View
2024-08-20Steven S WilliamsonAcquired 14245 @ 6.84View
2024-06-24Geoffrey Beran RoseDisposed 1184 @ 6.16View
2024-06-03Geoffrey Beran RoseDisposed 4297 @ 6.97View
2024-05-22Geoffrey Beran RoseDisposed 1184 @ 8.71View
2024-04-22Geoffrey Beran RoseDisposed 1184 @ 7.49View
2024-03-22Geoffrey Beran RoseDisposed 1184 @ 9.36View
2024-03-01David Aaron LehmanDisposed 4351 @ 9.06View
2024-02-22Geoffrey Beran RoseDisposed 1184 @ 14.2View
2024-02-15Glendon E French IIIDisposed 20000 @ 14.6View
2024-01-22Geoffrey Beran RoseDisposed 1184 @ 13.13View
2024-01-18Glendon E French IIIDisposed 10000 @ 12.77View
2023-12-22Geoffrey Beran RoseDisposed 1184 @ 12.75View
Monitoring Pulmonx Corp's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

Pulmonx Corp Management Team Effectiveness

The company has return on total asset (ROA) of (0.2004) % which means that it has lost $0.2004 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5199) %, meaning that it created substantial loss on money invested by shareholders. Pulmonx Corp's management efficiency ratios could be used to measure how well Pulmonx Corp manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.36. The current Return On Capital Employed is estimated to decrease to -0.42. At this time, Pulmonx Corp's Asset Turnover is most likely to slightly decrease in the upcoming years.
The current Common Stock Shares Outstanding is estimated to decrease to about 37.2 M. The Pulmonx Corp's current Net Loss is estimated to increase to about (50.4 M)

Pulmonx Corp Workforce Comparison

Pulmonx Corp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 25,948. Pulmonx Corp claims roughly 279 in number of employees contributing just under 2% to equities under Health Care industry.

Pulmonx Corp Profit Margins

The company has Profit Margin (PM) of (0.72) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.69) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.69.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.550.739
Way Down
Slightly volatile

Pulmonx Corp Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pulmonx Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pulmonx Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Pulmonx Corp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
0.125
1
8
 14,245 
 10,351 
2024-06-01
0.8182
9
11
 473,791 
 13,324 
2024-03-01
0.8235
14
17
 1,131,202 
 49,032 
2023-12-01
0.0476
1
21
 7,233 
 110,197 
2023-06-01
0.5385
7
13
 88,340 
 27,376 
2023-03-01
1.0
8
8
 1,094,500 
 6,629 
2022-12-01
0.5
5
10
 27,138 
 26,824 
2022-06-01
1.1667
7
6
 39,200 
 28,342 
2022-03-01
0.6667
8
12
 523,400 
 81,901 
2021-09-01
0.16
4
25
 16,095 
 2,634,488 
2021-06-01
0.5
18
36
 426,875 
 900,788 
2020-12-01
1.2381
26
21
 9,951,897 
 8,900,597 
2020-09-01
0.3
6
20
 150,000 
 6,383,040 

Pulmonx Corp Notable Stakeholders

A Pulmonx Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pulmonx Corp often face trade-offs trying to please all of them. Pulmonx Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pulmonx Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Pulmonx Corp Management Performance

The success or failure of an entity such as Pulmonx Corp often depends on how effective the management is. Pulmonx Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pulmonx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pulmonx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.35)(0.36)
Return On Capital Employed(0.40)(0.42)
Return On Assets(0.34)(0.36)
Return On Equity(0.51)(0.49)

Pulmonx Corp Workforce Analysis

Traditionally, organizations such as Pulmonx Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pulmonx Corp within its industry.

Pulmonx Corp Manpower Efficiency

Return on Pulmonx Corp Manpower

Revenue Per Employee246.1K
Revenue Per Executive4.9M
Net Loss Per Employee218.1K
Net Loss Per Executive4.3M
Working Capital Per Employee456.1K
Working Capital Per Executive9.1M

Complementary Tools for Pulmonx Stock analysis

When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Valuation
Check real value of public entities based on technical and fundamental data